Sympathoneural and adrenomedullary functional effects of ??2C-adrenoreceptor gene polymorphism in healthy humans
Authors:
- Alexander NeumeisterANAlexander Neumeister
- Dennis S. CharneyDCDennis S. Charney
- Inna BelferIBInna Belfer
- David GoldmanDGDavid Goldman
- 1 March 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 15 (3) , 143-149
Abstract
Objectives α2-Adrenoreceptors restrain sympathetic nervous outflows and inhibit release of noradrenaline from sympathetic nerves. In-frame deletion of the α2C-adrenoreceptor subtype (α2CDel322–325) increases the risk of congestive heart failure. Increased delivery of catecholamines to cardiovascular receptors might explain this increased risk. Methods Twenty-nine healthy African-Americans genotyped for α2-adrenoreceptor subtype polymorphisms underwent 3H-noradrenaline and 3H-adrenaline intravenous infusion and arterial blood sampling for measurements of rates of entry of endogenous noradrenaline and adrenaline into arterial plasma (total body spillovers) by the tracer dilution technique. Eleven subjects were homozygotes for the α2CDel322–325 polymorphism, nine heterozygotes, and nine non-carriers. Subjects were studied during supine rest and during and after i.v. infusion of the α2-adrenoreceptor antagonist, yohimbine. Results At rest, homozygotes for the α2CDel322–325 polymorphism had higher total body noradrenaline spillover than did heterozygotes (t=2.90, df=18, P=0.023) or non-carriers (t=3.22, df=18, P=0.010). Adrenaline spillover was higher in homozygotes than non-carriers (t=2.61, df=18, P=0.045). Administration of yohimbine produced larger, more sustained increments in noradrenaline spillover, heart rate, and anxiety in homozygotes than in the other groups. Conclusion In healthy people, α2CDel322–325 polymorphism is associated with increased sympathetic nervous and adrenomedullary hormonal activities, both during supine rest and during pharmacologically evoked catecholamine release. Polymorphisms of the α2C-adrenoreceptor may help explain individual differences in predisposition to a variety of disorders of catecholaminergic function, such as cardiovascular disorders, depression or anxiety disorders.Keywords
This publication has 24 references indexed in Scilit:
- Life Stress, Genes, and Depression: Multiple Pathways Lead to Increased Risk and New Opportunities for InterventionScience's STKE, 2004
- Sympathetic Augmentation in HypertensionHypertension, 2004
- Identification, course, and treatment of depression after admission for a cardiac condition: rationale and patient characteristics for the identifying depression as a comorbid condition (IDACC) projectAmerican Heart Journal, 2003
- Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathyJournal of Cardiac Failure, 2003
- An in-frame deletion in the α2C adrenergic receptor is common in African–AmericansMolecular Psychiatry, 2001
- A Four Amino Acid Deletion Polymorphism in the Third Intracellular Loop of the Human α2C-Adrenergic Receptor Confers Impaired Coupling to Multiple EffectorsJournal of Biological Chemistry, 2000
- PRESYNAPTIC RECEPTORSAnnual Review of Pharmacology and Toxicology, 1998
- Diverse tissue expression of rat alpha 2-adrenergic receptor genes.Hypertension, 1993
- Sympathetic reactivity during a yohimbine challenge test in essential hypertension.Hypertension, 1991
- Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic nerve varicosities1988